Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, April 03, 2019
Ajinomoto Bio-Pharma Services announced Jean-Baptiste Agnus has joined Aji Bio-Pharma as Vice President of Sales and Marketing.
read more
Tuesday, January 25, 2022
Ajinomoto Bio-Pharma Services announced that Tony O'Neill has joined Aji Bio-Pharma as Vice President of Compliance, US Operations. Mr. O'Neill brings extensive experience leading Quality, Manufacturing, and Operational Excellence Teams in the ...
read more
Tuesday, October 21, 2025
Ajinomoto Bio-Pharma Services and Gene Tools have announced a collaboration to expand access to phosphorodiamidate morpholino oligomer (PMO) therapeutics, a growing class of oligonucleotide drugs that show promise in treating genetic diseases such as...
read more
Wednesday, February 22, 2023
The development of a new enzyme for double strand oligonucleotide formation with high productivity has been announced by Ajinomoto Bio-Pharma Services, a leading provider of biopharmaceutical contract development and manufacturing services.
read more
Thursday, August 13, 2020
Ajinomoto Bio-Pharma has announced an expansion of small molecule manufacturing capabilities with the addition of a new production facility in India.
read more
Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce a manufacturing agreement expansion with AstraZeneca to include drug product ...
read more
Ajinomoto Bio-Pharma Services announced leadership changes at the company's site in San Diego, effective immediately.
read more
Ajinomoto Bio-Pharma Services provided an update on several of its capital projects currently underway in both the United States and Belgium.
read more
Ajinomoto Bio-Pharma Services has entered into a manufacturing agreement with Humanigen for the fill finish supply of lenzilumab currently being studied in a trial for COVID-19.
read more
Ajinomoto Bio-Pharma has announced a supply partnership with the DNDi for the supply of a CpG oligonucleotide, as part of a combination therapy used in the treatment of cutaneous leishmaniasis infections.
read more
Thursday, October 01, 2020
Ajinomoto Bio-Pharma has announce a supply partnership with the DNDi for the supply of a CpG oligonucleotide, as part of a combination therapy used in the treatment of cutaneous leishmaniasis infections.
read more
Monday, December 28, 2020
Ajinomoto Bio-Pharma Services and Revance Therapeutics have announced a commercial manufacturing agreement for the supply of DaxibotulinumtoxinA for Injection.
read more
Friday, February 17, 2017
Ajinomoto North America, Inc., a wholly owned subsidiary of Ajinomoto Co., Inc., now offers to North American customers’ pharmaceutical-grade L-cystine that is produced using fermentation technology
read more
Wednesday, March 06, 2013
Ajinomoto Co., Inc. (“Ajinomoto Co.”; TYO: 2802) and Althea Technologies, Inc. (“Althea Technologies”), announced today that they have entered into a definitive agreement by which Ajinomoto Co. will acquire Althea Technologies, a leading provider of ...
read more
Ajinomoto OmniChem, provider of small molecule API, contract development and manufacturing services, has announced the completion of a commercial scale manufacturing campaign that involves adapting a traditional multi-step batch process into a ...
read more